India, Feb. 11 -- image credit- freepik

The Indian Pharmaceutical Market (IPM) recorded monthly sales of Rs 21,208 crore in January 2026, registering a strong 10.2 per cent value growth and 1.8 per cent unit growth, according to PHARMARACK, with super groups continuing to drive market performance.

Cardiac therapies remained the largest contributor, accounting for 14 per cent of IPM value, and delivered a robust 14.0 per cent value growth along with 4.5 per cent unit growth during the month.

Anti-Diabetic therapies contributed 10 per cent to overall IPM value and emerged as one of the fastest-growing large segments, posting a sharp 15.2 per cent value growth supported by 5.5 per cent unit growth. Respiratory therapies, contributing 9 pe...